Literature DB >> 28012064

Patterns of care and treatment outcomes of patients with Craniopharyngioma in the national cancer database.

Yuan J Rao1, Comron Hassanzadeh2, Benjamin Fischer-Valuck1, Michael R Chicoine3, Albert H Kim3, Stephanie M Perkins1, Jiayi Huang4.   

Abstract

To investigate the patterns of care and outcomes in patients with craniopharyngioma in the National Cancer Data Base (NCDB). This study included 697 patients (166 pediatric and 531 adult cases) treated for craniopharyngioma between 2004 and 2012 in the NCDB. Adjuvant radiotherapy (RT) was defined if within 6 months of surgery. Limited surgery (LS) was defined as biopsy or subtotal resection. Proportional-hazards models were used to evaluate associations between covariates and overall survival (OS). A time-dependent analysis of RT was performed to account for early deaths after surgery. Median follow-up was 46 months. Overall, 21% of patients received adjuvant RT. Of patients with known surgical extent (n = 195), 71% had LS. Utilization of adjuvant RT increased from 18% in 2004-2007 to 24% in 2008-2012. Patterns of care regarding adjuvant RT or LS were not significantly different between adult and pediatric patients. Tumor size, low comorbidity, and LS were associated with increased utilization of adjuvant RT. The 5-year OS among patients treated with LS, LS+RT, and gross total resection were 75, 85, and 82% (p = 0.02). On multivariate analysis of the 195 patients with known surgical extent, LS+RT was associated with improved OS compared to LS (HR 0.22, 95% CI 0.05-0.99, p = 0.04), but was not significant when early deaths (<2 months from surgery) were removed to adjust for immortal-time bias. Medical practice regarding surgical approach and adjuvant RT are similar for pediatric and adult craniopharyngiomas. Immortal-time bias may confound assessment of OS for adjuvant RT. Prospective studies comparing adjuvant RT versus observation after LS are warranted.

Entities:  

Keywords:  Craniopharyngioma; National Cancer Database (NCDB); Patterns of care; Radiation; Surgery

Mesh:

Year:  2016        PMID: 28012064     DOI: 10.1007/s11060-016-2342-3

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  31 in total

Review 1.  The present and future management of childhood craniopharyngioma.

Authors:  R Hayward
Journal:  Childs Nerv Syst       Date:  1999-11       Impact factor: 1.475

Review 2.  Craniopharyngioma.

Authors:  John A Jane; Edward R Laws
Journal:  Pituitary       Date:  2006       Impact factor: 4.107

3.  The superiority of conservative resection and adjuvant radiation for craniopharyngiomas.

Authors:  Adam Schoenfeld; Melike Pekmezci; Michael J Barnes; Tarik Tihan; Nalin Gupta; Kathleen R Lamborn; Anu Banerjee; Sabine Mueller; Susan Chang; Mitchel S Berger; Daphne Haas-Kogan
Journal:  J Neurooncol       Date:  2012-02-15       Impact factor: 4.130

Review 4.  Craniopharyngioma: the pendulum of surgical management.

Authors:  Christian Sainte-Rose; Stéphanie Puget; Alison Wray; Michel Zerah; Jacques Grill; Raja Brauner; Nathalie Boddaert; Alain Pierre-Kahn
Journal:  Childs Nerv Syst       Date:  2005-08-03       Impact factor: 1.475

5.  Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients.

Authors:  M G Yaşargil; M Curcic; M Kis; G Siegenthaler; P J Teddy; P Roth
Journal:  J Neurosurg       Date:  1990-07       Impact factor: 5.115

6.  Outcome of craniopharyngioma in children: long-term complications and quality of life.

Authors:  Andrea Poretti; Michael A Grotzer; Karin Ribi; Eugen Schönle; Eugen Boltshauser
Journal:  Dev Med Child Neurol       Date:  2004-04       Impact factor: 5.449

7.  Trends in treatment and outcomes of pediatric craniopharyngioma, 1975-2011.

Authors:  Michal Cohen; Ute Bartels; Helen Branson; Abhaya V Kulkarni; Jill Hamilton
Journal:  Neuro Oncol       Date:  2013-03-13       Impact factor: 12.300

8.  Patterns of care for craniopharyngioma: survey of members of the american association of neurological surgeons.

Authors:  Todd C Hankinson; Nicholas O Palmeri; Sarah A Williams; Michelle R Torok; Cesar A Serrano; Nicholas K Foreman; Michael H Handler; Arthur K Liu
Journal:  Pediatr Neurosurg       Date:  2014-02-21       Impact factor: 1.162

9.  Limited utility despite accuracy of the national SEER dataset for the study of craniopharyngioma.

Authors:  Todd C Hankinson; Emma C Fields; Michelle R Torok; Brenda L Beaty; Michael H Handler; Nicholas K Foreman; Brent R O'neill; Arthur K Liu
Journal:  J Neurooncol       Date:  2012-08-23       Impact factor: 4.130

10.  Clinical outcome in children with craniopharyngioma treated with primary surgery and radiotherapy deferred until relapse.

Authors:  John A Kalapurakal; Stewart Goldman; Y C Hsieh; Tadanori Tomita; Maryanne H Marymont
Journal:  Med Pediatr Oncol       Date:  2003-04
View more
  6 in total

1.  Single fraction and multisession Gamma Knife radiosurgery for craniopharyngioma.

Authors:  Marco Losa; Valentina Pieri; Michele Bailo; Filippo Gagliardi; Lina Raffaella Barzaghi; Lorenzo Gioia; Antonella Del Vecchio; Angelo Bolognesi; Pietro Mortini
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

2.  Characteristics and overall survival in pediatric versus adult craniopharyngioma: a population-based study.

Authors:  Brandon M Lehrich; Khodayar Goshtasbi; Frank P K Hsu; Edward C Kuan
Journal:  Childs Nerv Syst       Date:  2021-02-28       Impact factor: 1.475

3.  Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort study.

Authors:  Michael S Rutenberg; Ronny L Rotondo; Dinesh Rao; Adam L Holtzman; Daniel J Indelicato; Soon Huh; Christopher G Morris; William M Mendenhall
Journal:  J Neurooncol       Date:  2020-02-21       Impact factor: 4.130

4.  Disease Control after Radiotherapy for Adult Craniopharyngioma: Clinical Outcomes from a Large Single-Institution Series.

Authors:  Michael S Rutenberg; Adam L Holtzman; Daniel J Indelicato; Soon Huh; Dinesh Rao; Peter J Fiester; Christopher G Morris; Daryoush Tavanaiepour; Robert J Amdur
Journal:  J Neurooncol       Date:  2022-03-12       Impact factor: 4.130

Review 5.  Fostering open collaboration in drug development for paediatric brain tumours.

Authors:  Jong Fu Wong; Elizabeth J Brown; Eleanor Williams; Alex N Bullock
Journal:  Biochem Soc Trans       Date:  2019-10-31       Impact factor: 5.407

6.  Proton therapy for craniopharyngioma in adults: a protocol for systematic review and meta-analysis.

Authors:  Pengtao Li; Jialing Wang; Aximujiang Axier; Kai Zhou; Jingwei Yun; Huayi Wang; Tingrong Zhang; Shaoshan Li
Journal:  BMJ Open       Date:  2021-06-01       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.